B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation
Xiaojie Wang(Shenyang Medical College), Garth L. Warnock(University of British Columbia)
Cited by 48
Related Papers
S100A12 is a promising biomarker in papillary thyroid cancer
|Scientific Reports|2020|34